Risdiplam
Tier B — Position earlyRisdiplam
Targets:SMN
Brand:EVRYSDI
Indications (approved):Spinal muscular atrophy
Regional status
Factories producing this API1
Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.
1 producing factories on file — sign in to view the named list (factory details are not shown to guests).
Sign in to view factories →Synthetic routes & intermediates2 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| RISD-001 | 19064-64-3Available | 3,6-dichloro-4-methylpyridazine |
| RISD-002 | 66346-87-0Available | 6-chloro-5-methylpyridazin-3-amine |
| RISD-003 | 64068-00-4Available | 6-chloro-4-methylpyridazin-3-amine |
| RISD-004 | 126-38-5Available | 1-bromo-2,2-dimethoxypropane |
| RISD-005 | 17412-23-6Available | 6-chloro-2,8-dimethylimidazo[1,2-b]pyridazine |
| RISD-006 | 73183-34-3Available | 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) |
| RISD-007 | 1825352-86-0Available | 2,8-dimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-b]pyridazine |
| RISD-008 | 1449598-86-0Available | 2-chloro-7-fluoro-4H-pyrido[1,2-a]pyrimidin-4-one |
| RISD-009 | 1825352-87-1Available | 2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-7-fluoro-4H-pyrido[1,2-a]pyrimidin-4-one |
| RISD-010 | 145122-56-1Available | 4,7-diazaspiro[2.5]octane hydrogen chloride |
| RISD-011 | 21717-96-4Available | 5-fluoropyridin-2-amine |
| RISD-012 | 108-59-8Available | dimethyl malonate |
| RISD-013 | 1449598-85-9Available | 7-fluoro-2-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one |
| Code | CAS No. | Intermediate |
|---|---|---|
| RISD-014 | 22059-21-8Available | 1-aminocyclopropanecarboxylic acid |
| RISD-015 | 42303-42-4Available | ethyl 1-aminocyclopropanecarboxylate hydrochloride |
| RISD-016 | 79-04-9Available | 2-chloroacetyl chloride |
| RISD-017 | 1279815-30-3Available | ethyl 1-(2-chloroacetamido)cyclopropanecarboxylate |
| RISD-018 | 1222106-43-5Available | 7-benzyl-4,7-diazaspiro[2.5]octane-5,8-dione |
| RISD-019 | 1222106-45-7Available | 7-benzyl-4,7-diazaspiro[2.5]octane |
| RISD-020 | 674792-03-1Available | tert-butyl 7-benzyl-4,7-diazaspiro[2.5]octane-4-carboxylate |
| RISD-021 | 6153-56-6Available | oxalic acid |
| RISD-022 | 2173992-48-6Available | tert-butyl 4,7-diazaspiro[2.5]octane-4-carboxylate hemioxalate |
| RISD-023 | 674792-08-6Available | tert-butyl 4,7-diazaspiro[2.5]octane-4-carboxylate |
| RISD-024 | 53939-30-3Available | 5-bromo-2-chloropyridine |
| RISD-025 | 2304625-40-7Available | tert-butyl 7-(6-chloropyridin-3-yl)-4,7-diazaspiro[2.5]octane-4-carboxylate |
| RISD-026 | 1838704-83-8Available | tert-butyl 7-(6-aminopyridin-3-yl)-4,7-diazaspiro[2.5]octane-4-carboxylate |
| RISD-027 | 541-16-2Available | di-tert-butyl malonate |
| RISD-028 | 2133298-72-1Available | tert-butyl 7-(2-hydroxy-4-oxo-4H-pyrido[1,2-a]pyrimidin-7-yl)-4,7-diazaspiro[2.5]octane-4-carboxylate |
| RISD-029 | 2133298-73-2Available | tert-butyl 7-(4-oxo-2-(tosyloxy)-4H-pyrido[1,2-a]pyrimidin-7-yl)-4,7-diazaspiro[2.5]octane-4-carboxylate |
| RISD-007 | 1825352-86-0Available | 2,8-dimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-b]pyridazine |
| RISD-030 | 2133298-74-3Available | tert-butyl 7-(2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-7-yl)-4,7-diazaspiro[2.5]octane-4-carboxylate |
| RISD-031 | 5469-69-2Available | 6-chloropyridazin-3-amine |
| RISD-032 | 446273-59-2Available | 4-bromo-6-chloropyridazin-3-amine |
| RISD-003 | 64068-00-4Available | 6-chloro-4-methylpyridazin-3-amine |
| RISD-033 | 108-21-4Available | isopropyl acetate |
| RISD-005 | 17412-23-6Available | 6-chloro-2,8-dimethylimidazo[1,2-b]pyridazine |
Frequently asked questions
What are the approved indications of Risdiplam?
Approved indications include: Spinal muscular atrophy.
When does the Risdiplam patent expire?
No public expiry year is available for Risdiplam yet; this page updates once verified.
How many synthesis routes are recorded for Risdiplam?
2 synthesis routes are recorded; the shortest is 7 steps with 12 mg (Risdiplam) total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Risdiplam intermediates?
33 intermediate CAS of Risdiplam are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Risdiplam intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29